Would i be right to think that the dmd drugs sarepta is marketing are similar to our drug in that they are targetting a small sub group with the disorder? Would be interesting to know the size of potential patients for their drugs. I guess im curious if it is larger target group than ours. Last i saw income for the dnd drug already on markey was 90 million plus last quarter?
PYC Price at posting:
5.6¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)